Company: IXHL
Filing Date: 2025-03-24
Form Type: S-3
Source: 0001013762-25-001587
Chunk: 10

Company: Incannex Healthcare Inc.
Filing Date: 2025-03-24
Form: S-3
Chunk 10
---
 are currently available for such issuance out of our authorized shares of common stock. As such
we are only registering 54,397,715 shares of our common stock issuable upon exercise of the Series A Warrants pursuant to the registration
statement on Form S-3 of which this prospectus is a part. Following and assuming approval of the Charter Amendment Proposal (as described
below), we will, as needed, seek to register the remaining 292,824,985 shares of our common stock issuable upon exercise of the Series
A Warrants.

<div align='center'>2</div>

The Warrants may not be exercised
if the aggregate number of shares of Common Stock beneficially owned by the holder thereof immediately following such exercise would exceed
a specified beneficial ownership limitation (4.99%/9.99%); provided, however, that a holder may increase or decrease the beneficial ownership
limitation by giving 61 days’ notice to the Company, but not to any percentage in excess of 9.99% (the “Beneficial Ownership
Limitation”).

In connection with the
Private Placement, the Company entered into a registration rights agreement with the selling stockholders on March 7, 2025 (the
“Registration Rights Agreement”), pursuant to which the Company agreed to use reasonable best efforts to register the
Securities for resale within thirty (30) days of the filing date of the registration statement (or, in the event of a “limited
review” or “full review” seventy-five (75) days) and also agreed to call a special meeting of stockholders no
later than sixty (60) days following the closing of the Private Placement for the approval of (i) the issuance of the Series A
Warrant Shares and adjustments to the exercise price and shares in the Series A Warrants as required pursuant to the rules and
regulations of the Nasdaq Stock Market LLC, and (ii) for an increase in the authorized number of shares of Common Stock as may be
required for the full exercise of the Series A Warrants. We are seeking stockholder approval (“the Stockholder
Approval”) to (i) to approve, for purposes of complying with Nasdaq Listing Rule 5635(d), the issuance of the Series A Warrant
Shares and certain provisions of the Series A Warrants, (ii) approve a proposed amendment to our Amended and Restated Certificate of
Incorporation to increase the total number of shares of common stock authorized for issuance thereunder